DNP completes Kyowa Pharma deal: 5 analysts rate DNP stock Accumulate
Published on 10/07/2026 at 01:54 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Dai Nippon Printing Co., Ltd. (ISIN JP3493800001) completed its acquisition of Kyowa Pharma Chemical on October 1, 2026, according to Jiji Press. The transaction brings an active pharmaceutical ingredient maker into DNP's medical and healthcare expansion and supports its plan to build a one-stop contract development and manufacturing organization.
Kyowa deal broadens healthcare strategy
DNP acquired all shares of Kyowa Pharma Chemical from Kyowa Hakko Bio, and the company is scheduled to change its name to DNP Pharma Chemical in February 2027, the same Jiji Press report states. DNP intends to combine research and development, active pharmaceutical ingredient production, drug formulation, and packaging to serve drugmakers across more stages of development.
The strategic logic is vertical integration rather than a simple capacity purchase. Kyowa Pharma Chemical contributes organic synthesis capabilities and production facilities, while DNP brings existing formulation and packaging operations; the combined offer is designed to shorten development cycles and strengthen supply reliability.
Revenue edges above prior year
DNP reported JPY 372.95 billion in revenue for the first quarter of fiscal 2027, compared with JPY 372.56 billion a year earlier, according to Yahoo Finance. The increase was JPY 0.39 billion, or 0.10 percent, while earnings reached JPY 23.58 billion and the reported profit margin was 6.32 percent in the same period.
For market context, Zonebourse listed five analysts in its September 18, 2026 consensus, with an average target of JPY 3,260.00 and an Accumulate recommendation. The same overview showed a high target of JPY 4,000.00 and a low target of JPY 2,500.00, leaving a wide range of views around the company's diversification strategy.
Tradegate quote predates acquisition
Dai Nippon Printing was last at EUR 16.40 on Tradegate on September 18, 2026 at 10:02 p.m. CEST. Its market capitalization was JPY 1.3 trillion on October 6, 2026, while the 52-week range was JPY 2,435.50 to JPY 3,364.00. Price source: substitute price Tradegate, Lang & Schwarz without data set.
The further course of trading is shown by the continuously updated company information and reporting calendar on the DNP Group investor relations page.
DNP stock facts
- Company: Dai Nippon Printing Co., Ltd.
- ISIN: JP3493800001
- Ticker: 7912
- Primary exchange: Japan Exchange
- Substitute price Tradegate: EUR 16.40 on September 18, 2026 at 10:02 p.m. CEST
- Market capitalization: JPY 1.3 trillion as of October 6, 2026
- 52-week range: JPY 2,435.50-3,364.00 as of October 6, 2026
- Sector / Industry: Industrials / Commercial printing services
- Index membership: Nikkei 225
- Next earnings date: November 13, 2026
